Cancer Treatment Reviews
Volume 31, Issue 3 , Pages 173-185 , May 2005

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: A systematic review

  • Helena J.H. van der Pal

      Affiliations

    • Department of Medical Oncology, F4-224, Academic Medical Centre, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 5665955; fax: +31 20 6919743
    • ,
  • Elvira C. van Dalen

      Affiliations

    • Department of Paediatric Oncology, Emma Children’s Hospital/Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • Leontien C.M. Kremer

      Affiliations

    • Department of Paediatric Clinical Epidemiology, Emma Children’s Hospital/Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • Piet J.M. Bakker

      Affiliations

    • Department of Medical Oncology, F4-224, Academic Medical Centre, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands
    • ,
  • Flora E. van Leeuwen

      Affiliations

    • Department of Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

References 

  1. Netherlands Cancer Registry . Childhood cancer in the Netherlands 1989–1997. Utrecht: Vereniging van Integrale Kankercentra; 2000;
  2. Heymans HSA, Caron HN. Cancer in children in the Netherlands (1989–1997). Ned Tijdschr Geneeskd. 2001;145:1442–1444
  3. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163–3172
  4. Moller TR, Garwicz S, Barlow L, et al. Association of the Nordic Cancer Registries; Nordic Society for Paediatric Hematology and Oncology. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol. 2001;19:3173–3181
  5. Green DM, Hyland A, Chung CS, et al. Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol. 1999;17:3207–3215
  6. Adams MJ, Hardenbergh PH, Constine LS, et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45:55–75
  7. Gardner MJ, Altman DG. Statistics with confidence. BMJ press; 1989;
  8. Laupacis A, Wells G, Richardson WS, et al. Users’ guides to the medical literature. V. How to use an article about prognosis. Evidence-based medicine working group. JAMA. 1994;272:234–237
  9. Grimes DA, Schultz KF. Cohort studies: marching towards outcomes. Lancet. 2002;359:341–345
  10. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997. Bone Marrow Transplant. 2001;28:283–287
  11. Glanzmann C, Kaufmann P, Jenni R, et al. Cardiac risk after mediastinal irradiation for Hodgkin’s disease. Radiother Oncol. 1998;46:51–62
  12. Viviani S, Bonadonna G, Santoro A, et al. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin’s disease: ten-year results. J Clin Oncol. 1996;14:1421–1430
  13. Vaughan Hudson B, Vaughan Hudson G, Linch DC, et al. Late mortality in young BNLI patients cured of Hodgkin’s disease. Ann Oncol. 1994;5(Suppl. 2):S65–S66
  14. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4–20 years after completing anthracycline therapy. JAMA. 1991;266:1672–1677
  15. Garaventa A, Porta F, Rondelli R, et al. Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Paediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant. 1992;10:419–423
  16. Boivin JF, Hutchison GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin’s disease. Cancer. 1992;69:1241–1247
  17. Kennedy BJ, Loeb V, Peterson V, et al. Survival in Hodgkin’s disease by stage and age. Med Pediatr Oncol. 1992;20:100–104
  18. Cosset JM, Henry-Amar M, Pellae-Cosset B, et al. Pericarditis and myocardial infarctions after Hodgkin’s disease therapy. Int J Radiat Oncol Biol Phys. 1991;21:447–449
  19. Tarbell NJ, Thompson L, Mauch P. Thoracic irradiation in Hodgkin’s disease: disease control and long-term complications. Int J Radiat Oncol Biol Phys. 1990;18:275–281
  20. Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol. 2002;20:2101–2108
  21. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001;19:191–196
  22. Lee CK, Aeppli D, Nierengarten ME. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin’s disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys. 2002;48:169–179
  23. Shah AB, Hudson MM, Poquette CA, et al. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin’s disease at St. Jude Children’s Research Hospital. Int J Radiat Oncol Biol Phys. 1999;44:867–877
  24. Hudson MM, Poquette CA, Lee J, et al. Increased mortality after successful treatment for Hodgkin’s disease. J Clin Oncol. 1998;16:3592–3600
  25. Krischer JP, Epstein S, Cuthbertson DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Paediatric Oncology Group experience. J Clin Oncol. 1997;15:1544–1552
  26. King V, Constine LS, Clark D, et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1996;36:881–889
  27. Mauch PM, Kalish LA, Marcus KC, et al. Long-Term Survival in Hodgkin’s Disease. Cancer J Sci Am. 1995;1:33
  28. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. J Clin Oncol. 1993;11:1208–1215
  29. Evans AE, Norkool P, Evans I, et al. Late effects of treatment for Wilms’ tumour. A report from the National Wilms’ Tumour Study Group. Cancer. 1991;67:331–336
  30. Thomas PR, Tefft M, D’Angio GJ, et al. Acute toxicities associated with radiation in the second National Wilms’ Tumour Study. J Clin Oncol. 1988;6:1694–1698
  31. Greenwood RD, Rosenthal A, Cassady R, et al. Constrictive pericarditis in childhood due to mediastinal irradiation. Circulation. 1974;50:1033–1039
  32. Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms’ tumour: a report from the National Wilms’ Tumour Study group. J Clin Oncol. 2001;19:1926–1934Green DM, Grigoriev YA, Nan B, et al. Correction to “Congestive heart failure after treatment for Wilms’ tumour”. J Clin Oncol. 2003;21:2447–2448

☆ This study was partly funded by Paediatric Cancer Research, Amsterdam, the Netherlands.

PII: S0305-7372(05)00058-7

doi: 10.1016/j.ctrv.2005.03.008

Cancer Treatment Reviews
Volume 31, Issue 3 , Pages 173-185 , May 2005

Article Tools

* Image Usage & Resolution